Neurocrine Biosciences Inc. is 10% Owner at Voyager Therapeutics, Inc. (VYGR). They have made 2 open-market trades across 1 company since 2019, most recently 2023-02-23.
2 open-market purchases totalling $178.0M since 2019, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VYGR | 8,575,316 | $16.2M |
Shares reported on the most recent Form 4, priced at the 2023-02-24 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.